Search for: "Deas v. Deas" Results 21 - 40 of 793
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Nov 2024, 9:33 pm by Kurt R. Karst
All DEA-registered practitioners may continue to prescribe via audio-visual telemedicine encounters schedule II-V controlled substances, and schedule III-narcotic controlled substances that are FDA-approved for opioid use disorder management and treatment. [read post]
21 Nov 2024, 9:05 pm by Anagha Vasudevarao
Supreme Court ruling in Securities and Exchange Commission (SEC) v. [read post]
19 Nov 2024, 2:52 pm by Little Health Law
 DEA-registered practitioners may issue prescriptions for all schedule II-V controlled substances to patients for whom they have not conducted an in-person medical evaluation, if all the following conditions are met: The prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of his/her professional practice; Continue reading › [read post]
24 Oct 2024, 9:05 pm by Samantha Heavner
Supreme Court decision, United States v. [read post]
15 Oct 2024, 4:37 am by Ambrosio Rodriguez
Schedule V Substances contained in Schedule V have a lower chance of dependency than Schedule IV substances. [read post]
20 Aug 2024, 7:58 am by Phil Dixon
” A DEA agent immediately told the defendant to stop talking and read him Miranda warnings, after which the defendant agreed to talk without a lawyer. [read post]
11 Jul 2024, 9:00 pm by Jon May
Law enforcement authorities that are part of the DOJ include the FBI, the DEA, and the ATF There are a host of other entities within the DOJ, but the ones mentioned do the lion’s share of the work and will be the most affected if Project 2025’s recommendations are implemented.2. [read post]